Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Barriers to ACEI/ARB Use in Proteinuric Chronic Kidney Disease: An Observational Study

Mayo Clinic Proceedings(2021)10.1016/j.mayocp.2020.12.038Source: DataRank Database

Barriers to ACEI/ARB Use in Proteinuric Chronic Kidney Disease: An Observational Study is a research paper published in Mayo Clinic Proceedings (2021). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access29 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.60)OA: greenTopics (28)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Jialin Han ORCID,Maria E. Montez‐Rath ORCID,Glenn M. Chertow ORCID,Ian E. McCoy ORCID

Live enrichment

PubMed:33952396 PMC:PMC8973200 OpenAlex:https://openalex.org/W3158548044

National Institutes of Health

Grant: 2K24DK085446

National Institutes of Health

Grant: 5T32DK007357

NIDDK NIH HHS

Grant: K24 DK085446

NIDDK NIH HHS

Grant: T32 DK007357

FWCI

2.60

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: https://www.elsevier.com/tdm/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8973200

publisherhttps://api.elsevier.com/content/article/PII:S0025619621000690?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0025619621000690?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.mayocp.2020.12.038

Fields of Study

Potassium and Related DisordersHeart Failure Treatment and ManagementDialysis and Renal Disease Management

MeSH Terms

AgedAged, 80 and overAngiotensin-Converting Enzyme InhibitorsFemaleHumansMaleMiddle AgedProteinuriaRisk FactorsDisease ProgressionRenal Insufficiency, ChronicAngiotensin Receptor Antagonists

Keywords

MedicineKidney diseaseHyperkalemiaNephrologyInternal medicineGuidelineOdds ratioMedical prescriptionIntensive care medicineAcute kidney injuryRenal functionPharmacologyPathology

Sustainable Development Goals

SDG 0: Good health and well-being

Barriers to ACEI/ARB Use in Proteinuric Chronic Kidney Disease: An Observational Study

FAIR Checklist

Authors (4)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)